For instance, combining an SGLT2 inhibitor with insulin or sulfonylurea can enhance the risk of hypoglycemia, and adding an SGLT2 inhibitor to a loop or thiazide diuretic may exaggerate volume depletion and hypotensive effects. Here, INS is linked to Hypoglycemia.